Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)

National Institutes of Health · Biomedical Research and Research Training

This Notice of Funding Opportunity (NOFO) encourages applications for NIGMS Biomedical Technology Optimization and Dissemination (BTOD) Centers to support late-stage technology optimization and sustainable dissemination of the technologies to the wider biomedical research community. A BTOD Center should be at the leading edge of its field with respect to both technology optimization and engagement with relevant research communities.BTOD projects must address biomedical research areas within the NIGMS mission. Potential applicants are strongly encouraged to consult with NIGMS staff about adherence of their proposed research strategy to the Institute's goals and mission and its responsiveness to this NOFO.

Grant800 days left
Type
Grant
Deadline

Eligibility

Public and State controlled institutions of higher education; Native American tribal governments (Federally recognized); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Special district governments; Private institutions of higher education; Small businesses; Public housing authorities/Indian housing authorities; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; Independent school districts; Native American tribal organizations (other than Federally recognized tribal governments); State governments; City or township governments. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/Foreign Collaborations: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S.

Open funding calls · National Institutes of Health

Open calls
  1. NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
  2. NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
  3. BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
  4. NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
  5. SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)

News on this topic

  1. Chips with one million Cs3Sb2−xBixBr9−yIy microcrystals map composition–property links in perovskitoids
  2. MIT and Whitehead Institute build whole-body single-cell atlas of adult Danionella cerebrum from 600,000 cells
  3. Transient contacts between filaments explain the elasticity of branched actin networks
  4. Engineered E. coli produces 1.805 g/L of antibiotic Angustmycin A in a 1.2-L bioreactor
  5. MEPhI builds TREK detector of about 250 square metres to study the muon puzzle in cosmic rays
More
Follow us

Type at least two letters — results appear instantly

↑↓to choose↵to openescto close